These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 18599586)
1. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. Kenny S; Duval C; Sammut SJ; Steele I; Pritchard DM; Atherton JC; Argent RH; Dimaline R; Dockray GJ; Varro A Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G431-41. PubMed ID: 18599586 [TBL] [Abstract][Full Text] [Related]
2. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653 [TBL] [Abstract][Full Text] [Related]
3. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells. Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392 [TBL] [Abstract][Full Text] [Related]
4. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126 [TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role. Plebani M; Herszènyi L; Carraro P; De Paoli M; Roveroni G; Cardin R; Tulassay Z; Naccarato R; Farinati F Clin Exp Metastasis; 1997 Jul; 15(4):418-25. PubMed ID: 9219730 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395 [TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934 [TBL] [Abstract][Full Text] [Related]
10. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728 [TBL] [Abstract][Full Text] [Related]
11. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704 [TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases. Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085 [TBL] [Abstract][Full Text] [Related]
13. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mahanivong C; Yu J; Huang S Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542 [TBL] [Abstract][Full Text] [Related]
14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
15. Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues. Hong SI; Park IC; Son YS; Lee SH; Kim BG; Lee JI; Lee TW; Kook YH; Min YI; Hong WS J Korean Med Sci; 1996 Feb; 11(1):33-7. PubMed ID: 8703368 [TBL] [Abstract][Full Text] [Related]